QB3 logo

QB3

North America, California, United States, San Francisco

Description

California Institute for Quantitative Biosciences is a group of research institutes created for the benefit of the bioeconomical society.

Investor Profile

QB3 has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B, Grant rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Bioinformatics.

Stage Focus

  • Series Unknown (33%)
  • Series B (33%)
  • Grant (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Bioinformatics
  • Genetics
  • Oncology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Apps
  • Consumer
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QB3 frequently co-invest with?

Foothill Ventures
North America, California, United States, Los Altos
Co-Investments: 1
Genoa Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Keiretsu Capital
North America, Washington, United States, Seattle
Co-Investments: 1
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
Green Park & Golf Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
Chan Zuckerberg Initiative
North America, California, United States, Palo Alto
Co-Investments: 1
Keiretsu Forum
North America, California, United States, Orinda
Co-Investments: 1
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 1
JLABS
North America, California, United States, San Diego
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does QB3 often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
JF
North America, California, United States
Shared Deals: 1

What are some of recent deals done by QB3?

Dogma BioTech

Bogotá, Distrito Especial, Colombia

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

BiotechnologyLife ScienceManufacturing
GrantJul 10, 2025
Amount Raised: $100,000
Mission Bio

San Francisco, California, United States

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

BioinformaticsBiotechnologyGeneticsHealth CareOncology
Series UnknownJun 29, 2018
Pionyr Immunotherapeutics

South San Francisco, California, United States

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BDec 13, 2017
Amount Raised: $62,000,000
Lioness

Berkeley, California, United States

Destigmatizing women's sexual health through information and conversation.

AppsConsumerEducationHealth CareLifestyleSex TechSoftwareWomen's
GrantMar 9, 2014

Find More Investors Like QB3

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

QB3 | Pipeseed